Navigation Links
Discredited Drug may Be Used to Aid Mental Development in Down’s Syndrome Patient

Researchers who experimented with a drug used previously in the treatment of epilepsy are planning to extend the study from lab rats// to human subjects.

The researchers found that the drug called pentylenetetrazole, or PTZ, when administered daily to the rats which were bred to have genetic similarities to Down’s Syndrome patients, elicited marked improvement in learning abilities.

Down's syndrome is the most frequent genetic cause of mental retardation and occurs equally around the world, in about one in every 800 births. About 5,000 children born in the United States each year have Down syndrome.

It is caused by the presence of a third chromosome, known as chromosome 21. Most people have two copies of each chromosome and the additional activity of the genes on the third copy of chromosome 21 is believed to cause the symptoms of Down syndrome.

The researchers were led by Craig Garner, a professor of psychiatry and a director of the Down Syndrome Research Center at California's Stanford University and they published results in the journal Nature Neuroscience.

Fabian Fernandez, a student in Garner's lab, was exploring the possibility that the brains of Down's patients are too strongly affected by a chemical called GABA, a neurotransmitter, or message-carrying chemical. This stops brain cells from becoming too excited.

In general, learning involves neuronal excitation in certain parts of the brain.

Says Garner "For example, caffeine, which is a stimulant, can make us more attentive and aware, and enhance learning."

PTZ does this by causing more GABA to be available in the brain. Overdoing this process can cause seizures. PTZ was once used to study epilepsy but it is no longer approved for use in people.

Fernandez gave daily doses of PTZ to the mice for about 2 weeks.

The mice were better able to navigate mazes and recognize new objects after receiving the drug, and were on par with normal mice.

The gains continued for months after the treatment stopped. This makes the scientists believe that as it can cause long-term changes in the brain, it can probably be used as a psychotherapy drug.

Concludes Garner: We think we're slowly being able to understand what's causing reduced cognitive ability in people with Down syndrome and there are new approaches and strategies that could improve their quality of life.
ANN
'"/>




Related medicine news :

1. Link between Mercury based Vaccines and Autism Discredited
2. Mental illness a key factor in suicide
3. Mental retardation linked to brain protein
4. Mental growth in babies at risk
5. Reduced Fatigue Boosts Mental Health
6. Mental Health Services for Children
7. Mentally Demanding Jobs Found To Reduce The Risk Of Alzheimer’
8. Diabetics To Seek Mental Counseling To Cope With Stress
9. Exercise Can Decrease Mental Decline
10. Low Socioeconomic Status May Lead To Mental Illness
11. Mental health may deteriorate as early as in the teens
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... Flottman ... and outserts. As a means of expanding capabilities Flottman has added a ... to individually code professional inserts (PIs) and patient package inserts (PPIs) that will ...
(Date:12/9/2016)... , ... December 09, 2016 , ... An inventor from ... to safely ride all types of amusement park rides. , The patent-pending SAFETY STRAP ... is easy to use and could be set up in a matter of minutes, ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying ... Va. "I thought that if the nebulizer had a more child-friendly design, then children ... , He developed the patent-pending NEBY to avoid the need to deliver medication via ...
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec 9, 2016 Research ... Screening Market - Forecast to 2021" report to their ... ... of open innovative models in the pharmaceutical and biotechnology industry ... and rising government funding. Emerging markets and growing research activities ...
(Date:12/9/2016)...  RxWiki Inc., a digital health company that powers ... thousands of pharmacies through its Digital Pharmacist SaaS platform, ... "50 on Fire" Award in the Health and Life ... the award as one of Austin,s fastest growing companies," ... RxWiki. "Our platform gives independent retail pharmacies the digital ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, ... AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) ... ,LpxC, for the treatment of bacterial infections including ... been recognized as an attractive antibacterial target for ... lack of suitable chemical starting points has hampered ...
Breaking Medicine Technology: